MARK ANDERSON & ASSOCIATES, INCORPORATED – Trademark Portfolio

Entity Type: 03

MARK ANDERSON & ASSOCIATES, INCORPORATED holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include EMCARE and OVAGEN. The owner is based in SPRING VALLEY, WI.

303 SOUTH MCKAY AVENUE

SPRING VALLEY, WI 54767

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

EMCARE
EMCARE
Registered 2004
OVAGEN
OVAGEN
Registered 2004

Trademark Classifications

MARK ANDERSON & ASSOCIATES, INCORPORATED's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does MARK ANDERSON & ASSOCIATES, INCORPORATED have?

MARK ANDERSON & ASSOCIATES, INCORPORATED has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does MARK ANDERSON & ASSOCIATES, INCORPORATED file in?

MARK ANDERSON & ASSOCIATES, INCORPORATED files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are MARK ANDERSON & ASSOCIATES, INCORPORATED's most well-known trademarks?

MARK ANDERSON & ASSOCIATES, INCORPORATED's registered trademark portfolio includes well-known marks such as EMCARE and OVAGEN. These are among 2 currently registered trademarks in the portfolio.

What is MARK ANDERSON & ASSOCIATES, INCORPORATED's trademark registration success rate?

MARK ANDERSON & ASSOCIATES, INCORPORATED has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.